SI1285659T1 - Uporaba klaritromicinskih sestavkov za pripravo zdravila za zdravljenje deformirajocega artritisa - Google Patents

Uporaba klaritromicinskih sestavkov za pripravo zdravila za zdravljenje deformirajocega artritisa

Info

Publication number
SI1285659T1
SI1285659T1 SI200130767T SI200130767T SI1285659T1 SI 1285659 T1 SI1285659 T1 SI 1285659T1 SI 200130767 T SI200130767 T SI 200130767T SI 200130767 T SI200130767 T SI 200130767T SI 1285659 T1 SI1285659 T1 SI 1285659T1
Authority
SI
Slovenia
Prior art keywords
treatment
medicament
manufacture
arthritis deformans
clarithromycin
Prior art date
Application number
SI200130767T
Other languages
English (en)
Inventor
Gianantonio Saviola
Original Assignee
Fond Salvatore Maugeri Clinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Salvatore Maugeri Clinica filed Critical Fond Salvatore Maugeri Clinica
Publication of SI1285659T1 publication Critical patent/SI1285659T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SI200130767T 2001-08-13 2001-08-13 Uporaba klaritromicinskih sestavkov za pripravo zdravila za zdravljenje deformirajocega artritisa SI1285659T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01119436A EP1285659B1 (en) 2001-08-13 2001-08-13 Use of clarithromycin compositions in the manufacture of a medicament for the treatment of arthritis deformans

Publications (1)

Publication Number Publication Date
SI1285659T1 true SI1285659T1 (sl) 2008-02-29

Family

ID=8178305

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130767T SI1285659T1 (sl) 2001-08-13 2001-08-13 Uporaba klaritromicinskih sestavkov za pripravo zdravila za zdravljenje deformirajocega artritisa

Country Status (7)

Country Link
EP (1) EP1285659B1 (sl)
AT (1) ATE365557T1 (sl)
DE (1) DE60129133T2 (sl)
DK (1) DK1285659T3 (sl)
ES (1) ES2288898T3 (sl)
PT (1) PT1285659E (sl)
SI (1) SI1285659T1 (sl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2219659C (en) * 1995-06-09 2008-03-18 Novartis Ag Rapamycin derivatives
AU3501700A (en) * 1999-02-26 2000-09-14 Human Genome Sciences, Inc. Human endokine alpha and methods of use
TR200000054A2 (tr) * 2000-01-05 2001-08-21 Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇ Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
CA2397092A1 (en) * 2000-01-11 2001-07-19 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs

Also Published As

Publication number Publication date
DE60129133T2 (de) 2008-03-06
EP1285659A1 (en) 2003-02-26
PT1285659E (pt) 2007-10-09
DK1285659T3 (da) 2007-10-29
EP1285659B1 (en) 2007-06-27
DE60129133D1 (de) 2007-08-09
ATE365557T1 (de) 2007-07-15
ES2288898T3 (es) 2008-02-01

Similar Documents

Publication Publication Date Title
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
HUP0202719A3 (en) Pharmaceutical compositions for the treatment of female sexual dysfunctions
IL196301A0 (en) Medicament for the treatment of hapatitis c
EP1407785A4 (en) MEDICAL COMPOSITIONS
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
HK1065944A1 (en) Medicinal compositions
GB0117618D0 (en) Pharmaceutical dosage form
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
SE0102315D0 (sv) Compounds
PL367180A1 (en) Stabilized oral pharmaceutical composition
EP1390029A4 (en) PHENYLINDOLES FOR THE TREATMENT OF HIV INFECTION
IL159532A0 (en) Enteral formulations
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
IL161070A0 (en) Compositions for the treatment of infectious diseases
HUP0400850A3 (en) Oral pharmaceutical compositions
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
HK1065257A1 (en) Medicinal composition
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
HUP0500638A2 (en) Flashmelt oral dosage formulation
GR1004358B (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
SI1285659T1 (sl) Uporaba klaritromicinskih sestavkov za pripravo zdravila za zdravljenje deformirajocega artritisa
ATE286893T1 (de) 2h-1-benzopyran-derivative, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
EP1361866A4 (en) EMULSIONS AS SOLID DOSAGE FORMS FOR ORAL ADMINISTRATION